Home Newsfeeds Japanese Fund Buys Onsemi Chip Plant for $135M

Japanese Fund Buys Onsemi Chip Plant for $135M

-Nikkei https://asia.nikkei.com/Business/Business-deals/Japanese-fund-buys-Onsemi-chip-plant-for-135m

byCharles Gross

October 31, 2022

1 minute read

-Nikkei

https://asia.nikkei.com/Business/Business-deals/Japanese-fund-buys-Onsemi-chip-plant-for-135m

What’s Going On With Rail Vision Stock?

By Erica Kollmann

January 23, 1:58 PM

Rail Vision Ltd. (NASDAQ:RVSN) shares are rocketing higher Tuesday. The company announced that its Main Line system had obtained formal certifications for European Union (EU) railway standards on Monday. Rail Vision said that the EU certification underscores its commitment achievement to quality, safety, and innovation in the railway technology market.

RVSN

Wall Street Journal, Citing Documents And Interviews With Former Employees, Reported Binance Formulated Plan To Elude U.S. Authorities

By Charles Gross

March 5, 12:40 PM

https://www.wsj.com/articles/texts-from-crypto-giant-binance-reveal-plan-to-elude-u-s-authorities-3a17ddeb

BTC

Wintrust Financial Q4 EPS $2.23 Misses $2.58 Estimate, Sales $550.65M Miss $553.28M Estimate

By Michael Horton

January 18, 5:57 PM

Wintrust Financial (NASDAQ:WTFC) reported quarterly earnings of $2.23 per share which missed the analyst consensus estimate of $2.58 by 13.57 percent. This is a 41.14 percent increase over earnings of $1.58 per share

WTFC

News

Roivant, Pfizer Form New Vant Company Focused On Developing TL1A Drug Candidate For Inflammatory And Fibrotic Diseases

By Benzinga Newsdesk

December 1, 9:01 AM

Roivant to develop PF-06480605 (now RVT-3101), a potential first in class, fully human monoclonal antibody that blocks tumor necrosis factor-like ligand 1A (TL1A), a cytokine believed to play a key role in inflammation

PFE

Japanese Fund Buys Onsemi Chip Plant for $135M

Related Posts

What’s Going On With Rail Vision Stock?

Wall Street Journal, Citing Documents And Interviews With Former Employees, Reported Binance Formulated Plan To Elude U.S. Authorities

Wintrust Financial Q4 EPS $2.23 Misses $2.58 Estimate, Sales $550.65M Miss $553.28M Estimate

Roivant, Pfizer Form New Vant Company Focused On Developing TL1A Drug Candidate For Inflammatory And Fibrotic Diseases